In this issue:
Four vs six cycles of CHOP in B-cell lymphoma
R-CVP vs R-CHOP induction for indolent lymphoma
Early risk stratification for DLBCL
Cost effectiveness of ibrutinib vs chemo in CLL
Pembrolizumab in R/R PMBCL
Long-term follow-up of low dose dasatinib in chronic-phase CLL
Improved CNS control of paediatric ALL without cranial irradiation
20-year follow-up of paediatric ALL without cranial radiotherapy
Prognostic significance of MYC mutation in DLBCL
Impact of variant allele frequency in AML
Please login below to download this issue (PDF)